Lalitha M. Janaki, MD Minimize

Lalitha M Janaki. M .D .FACR.

RADIATION ONCOLOGIST

 

CURRICULUM VITAE

 

OFFICE:                   Christus Spohn Cancer Center

14120 Northwest Blvd.
Corpus Christi, Texas 78410

and 1415 Santa Fe
Corpus Christi, Texas 78404

 

PROFILE:                  Dr. Janaki, born in Muthkhed, India, December 9, 1943 and is one of seven children. She obtained her medical degree from
Osmania University of India. She has been married for 43 years to Mr. Madhava Gopal.  They have two children, born in the United States. Most recently, she has been awarded, Fellow of American College of Radiology, the highest national honor of this kind given by the College. As of July 1, 2014, a member of the Christus Health Group.

 

 

NATIONALTY:        U.S. Citizen

 

LICENSE:                  TEXAS, license # F7794

 

DEGREES:                Doctor of Medicine

                                    Osmania Medical College, Hyderabad, India – 1969.

                                   

CERTIFICATION:   American Board of Radiology in Therapeutic Radiology

 

MEDICAL

SCHOOL:                 Osmania Medical College, Hyderabad, India

 

INTERSHIP:             St. Josef’s Hospital, Rudesheim, West Germany

                                    Internal Medicine, 1971-1972

 

                                    2nd General Hospital, Landstuhl, Germany

                                    Outpatient Clinic & ER General Medical MD, 1972 - 1975

 

                                    Oakforest Hospital, Oakforest, Illinois

                                    Geriatric Medicine, 1975 – 1976

 

                                    Michael Reese Medical Center, Chicago, Illinois

                                    Radiation Oncology, 1976 – 1979

 

 

MILITARY EXPERIENCE:   Colonel, U.S. Armed Forces

                                               serving 16 years, both active and reserves.

                                    Operation Desert Shield & Operation Desert Storm – 1991.

ACADEMIC

POSITIONS:              Clinical Assistant Professor

University of Texas Health Science Center, San Antonio, Texas

University of Texas Galveston Medical Branch, Galveston, Texas

 

AWARDS &

ACHIEVEMENTS:   Certificate of Achievement

United States Army

European Command, 1973

 

Physician’s Recognition Award

1976, 1979, 1982, 1985, 1988, 1991, 1994, 1998, and 2002

 

Army Commendation Medal

Army National Defense Service Medal

Overseas Service Ribbon

 

YMCA Career Award

 

Nueces County Medical Society, President - 2005

 

TMA Delegate

 

National Honor Award

Fellow of American College of Radiology

 

 

 

 

CLINICAL

RESEARCH

EXPERIENCE:          

A Randomized, Double-blind, Multicenter, Comparative Trial of I.V. Study Drug (Two Doses) Versus I.V. Standard Drug, as an Adjunct to Standard Therapies, in the Treatment of Multiple Myeloma and Breast Cancer Patients with  Cancer-Related Bone Lesions.

                       

A Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Safety and Efficacy of Study Drug (Two Doses) Administered Intravenously as an Adjuvant to Anticancer Therapy to Patients with any Cancer with Bone Metastases Other than Breast Cancer, Multiple Myeloma or Prostate Cancer

 

A Randomized, Double-blind, Placebo-controlled, Multicenter, Comparative, Safety and Efficacy Study of I.V. Study Drug (Two Doses) in Prostate Cancer Patients with Metastatic Bone Lesions Receiving Antineoplastic Therapy

 

A Randomized, Phase IV, Multicenter Trial Comparing Two   Dosing Regimens of **** (Weekly x 4 / 2-Week Rest Versus Every 2-Weeks) in Patients with Metastatic Colorectal  Cancer After Treatment-Failure with ****

 

A Randomized Phase III Trial of ****/**** Versus ****/****/**** for the Treatment of Extensive Small Cell Lung Cancer

 

A Phase II/III Study of **** vs. **** in Subjects with Newly Diagnosed CML

 

A Phase III Double-blind Evaluation of the Optimal Schedule of Study Drug in Patients with Breast Cancer Receiving Chemotherapy with Docetaxel, Doxorubicin and Cylophasphamide

 

A Three Arm Double-blind Parallel Group Phase IIb Study to Investigate the Safety and Efficacy of Study Drug Versus Metoclopramide Versus Study Drug Plus Metoclopramide in the Prevention of Delayed Nausea and Vomiting in Subjects Receiving Cisplatin Chemotherapy

 

Comparison of the Effect of Study Drug and Anastrozole in Subjects with Breast Cancer Progressing After an Initial Response to Tamoxifen or Relapsing After Tamoxifen Given as Adjuvant to Surgery: A Prospective Double-blind Phase III Trial

 

 

LALITHA JANAKI, MD

 

CLINICAL

RESEARCH

EXPERIENCE:          A Study to Determine the Effective Dose and Method of  Conversion to Study Drug in Patients Receiving Standard Pain Medication for Moderate or Severe Cancer Pain

 

A Double-blind, Randomized Phase III Study of Study Drug plus Prednisone or Placebo plus Prednisone in Patients with Symptomatic Hormone-Refractory Prostate Cancer

 

A Multicenter Multinational Randomized Phase III Study of Study Drug plus Cisplatin Versus Study Drug plus Carboplatin Versus Vinorelbine Plus Cisplatin in Chemotherapy-naïve Patients with Locally Advanced (Stage IIIB) and Recurrent or Metastatic (Stage IV) Non-Small Cell Lung Cancer

 

Critical Evaluation of Once Weekly Dosing of Study Drug in  Anemic Cancer Patients Receiving Radiation Therapy Either Concomitantly or Sequentially with Chemotherapy

 

An Open-Label Combination Study of Oral **** and Standard **** Therapy as First or Second Line Therapy in Women with  Metastatic Breast Carcinoma

 

**** in an Alternative Dose (The **** Trial): Treatment of Patients with Metastatic Renal Cell Carcinoma with Low-Dose ****

 

Randomized, Double-Blind, Multicenter, Comparative Trial   of I.V. **** (4 mg or 8mg) Versus I.V. **** (90 mg), as an Adjunct to Standard Therapies, in the Treatment of Multiple Myeloma and Breast Cancer Patients with Cancer-Related Bone Lesions [Extension]

 

A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of **** (5,000 IU Subcutaneously) in Preventing Catheter-Related Complications When Given Daily to Cancer Patients with Central Venous Catheters

 

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Matrix Metalloprotease Inhibitor **** in Combination with **** and **** in Patients Having Metastatic or Recurrent Non-Small Cell Lung Cancer

 

 

 

A Multicenter, Phase III, Randomized Trial Comparing **** Administered Either Weekly or Every Three Weeks in   Combination with **** Versus **** in Combination with ****   for Metastatic Hormone Refractory Prostate Cancer

 

A Phase II Study of **** (**** + ****) Given as a Twice-Daily Regimen in the Treatment of Patients with Metastatic Colorectal Cancer

 

 

RESEARCH

PROTOCOLS:         Radiation Therapy Coordinator for Southwest Oncology Group Protocols

#8269 – Concurrent Chemo-Radiotherapy Limited Small Cell Carcinoma of Lung

#8210 – A Comparison of Aggressive Radiation Therapy and Chemotherapy for Limited Carcinoma of Pancreas

Phase 1 / 2 study with concurrent Radiation Therapy followed by Chemotherapy with inoperable stage III A/B non-small cell lung cancer.

 

BIBLIOGRAPHY:     Michael Brannon, M.D. and Lalitha M. Janaki, M.D.

“Radiation Therapy for Grave’s Disease”

American Journal of Opthamology 96: 96-100, 1983

 

Joseph D. McCracken, M.D., Lalitha M. Janaki, M.D., et al

“Adjuvant Intrahepatic Chemotherapy with Mitomycin-C and 5-FU with Hepatic Radiation in High Risk Patients in Carcinoam of Colon State II Pilot”

Cancer 7, 1983

 

Lalitha M. Janaki, M.D., et al

“Intaoral-Extraoral Radiation Carrier for Carcinoma of the Lip”

Journal of Prosthetic Dentistry 51 (1): 70, 1984

 

Lalitha M. Janaki, M.D., et al

“Carcinoma Recurrence in the Tracheal Stoma; Treatment with Intracavity Radiation by Modification of Tracheostomy Tube”

Radiology 159: 275, 1986

 

Lalitha M. Janaki, M.D., J.D. McCracken, M.D., et al

“Limited Stage Small Cell Carcinoma of Lung”

Seminars in Oncology 13: Suppl 31-36, 1986

“Concurrent Chemoradiation Therapy for Limited Small Carcinoma of Lung”

Journal of Clinical Oncology 8: 892-898, 1990

 

Lalitha M. Janaki, M.D., Lionel Cohen, M.D., et al

“Treatment of Carcinoma of Esophagus with Radiation Therapy”

Proceedings of Astro Meetings 10, 1978

 

J.D. McCracken, M.D., Lalitha M. Janaki, M.D., et al

“Concurrent Radiotherapy – Small Cell Carcinoma of Lung – Recent Advances in Chemotherapy”

Proceedings 14th International Congress of Chemotherapy

Kyoto, Japan 1985

 

Madhava Baikadi, M.D. and Lalitha Janaki, M.D.

“Interstitial Dosimetry Using CT Scan in the Treatment of the Primary Breast Cancer"

Fourth Annual Endocurie Society Meeting

Key Biscayne, Florida

November 1982

 

Madhava Baikadi, M.D. and Lalitha M. Janaki, M.D.

“Treatment of Lip Cancer with Implant”

Fourth Annual Endocurie Society Meeting

Key Biscayne, Florida

November 1982

 

Lalitha M. Janaki, M.D. and Michael Brannon, M.D.

“Radiation Therapy for Dysthyroid Ophthalmopathy”

American Association of Opthalmologists Meeting

San Francisco, California

November 1982

 

Lalitha M. Janaki, M.D., et al

“Treatment Tolerance and Toxicities of Concurrent Chemo-Radiation Therapy for Limited Small Cell Carcinoma”

ASTRO

Washington, D.C. 1984

 

 

“Toxicities Concomitant Chemo-Radiotherapy for Limited Small  Cell Carcinoma of Lung”

ASCO

Houston, Texas

May 1985

 

Lalitha M. Janaki, M.D., et al

“Improved Response Rate-Median Survival Limited Small Cell Carcinoma of Lung”

International Meeting Small Cell Lung Cancer

Ravenna, Italy

March 1987

 

J.D. McCracken, M.D., Lalitha M. Janaki, M.D., et al

“Small Cell Carcinoma of Lung Survival Status and Update”

ASCO

Atlanta, Georgia

May 1987

 

J.D. McCracken, M.D., Lalitha M. Janaki, M.D., et al

“Small Cell Carcinoma of Lung Survival Status and Update”

International Chemotherapy Conference

Istanbul, Turkey

July 1987

 

Lalitha M. Janaki, M.D., et al

“Update Survival Small Cell Carcinoma of the Lung”

ASTRO 29th Annual Meeting

Boston, Massachusetts

October 1987

 

Lalitha M. Janaki, M.D., et al

“Concurrent Chemoradiation Therapy for Limited Small Cell Carcinoma of Lung Pattern of Failure and Time Dose Relationship”

17th International Congress of Radiology

Paris, France

July 1989

  

 

“Radiotherapy of Lung Cancer”

1st Cancer Symposium Mediciti – Share USA – Share India

Hyderabad, India

December 1992

 

Lalitha M. Janaki, M.D., Dori Rector, M.S., A. Tirussi, M.D., et al

“Patterns of Failure and 2nd Malignancies from SWOG 8269”

ASCO

Dallas, Texas

May 1994

 

A. Tirussi, M.D., Lalitha M. Janaki, M.D., Dori Rector, M.S.,

B.   et al

“Long Term Follow-up 2nd Tumors – SWOG”

Submitted 7th World Congress on Lung Cancer

Colorado Springs, Colorado

1996

Photos Minimize
dr. lalitha Janaki 
 dr. lalitha Janaki
 dr. lalitha Janaki
 dr. lalitha Janaki
 dr. lalitha Janaki
 dr. lalitha Janaki
 dr. lalitha Janaki